Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 406 | 0 | 1,292 | 3,825 | 2,369 |
| Gross Profit | 406 | N/A | 1,292 | 3,825 | 2,369 |
| Operating Expenses | 43,311 | 44,377 | 40,440 | 15,474 | 45,863 |
| Operating Income | -42,905 | -44,377 | -39,148 | -11,649 | -43,494 |
| Interest Expense | 5,014 | 5,020 | 4,905 | 3,455 | 1,850 |
| Other Income | 2,049 | 3,885 | 4,228 | 7,675 | -3,575 |
| Pre-tax Income | -45,870 | -45,512 | -39,825 | -7,429 | -48,919 |
| Income Tax | -21 | 40 | -14 | 19,522 | -6,152 |
| Net Income Continuous | -45,849 | -45,552 | -39,811 | -26,951 | -42,767 |
| Net Income | $-45,849 | $-45,552 | $-39,811 | $-26,951 | $-42,767 |
| EPS Basic Total Ops | -0.26 | -0.26 | -0.23 | -0.23 | -0.47 |
| EPS Basic Continuous Ops | -0.26 | -0.26 | -0.23 | -0.23 | -0.47 |
| EPS Diluted Total Ops | -0.26 | -0.26 | -0.23 | -0.23 | -0.47 |
| EPS Diluted Continuous Ops | -0.26 | -0.26 | -0.23 | -0.23 | -0.47 |
| EBITDA(a) | $-41,526 | $-42,865 | $-37,249 | $-10,000 | $-41,707 |